Bath & Body Works Inc vs Health Care Select Sector SPDR Fund — how do they compare? Bath & Body Works Inc trades at $18.21 (market cap $3.81B), while Health Care Select Sector SPDR Fund trades at $168.74. The key difference: Bath & Body Works Inc pays a 4.24% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Bath & Body Works Inc nearer its low. Which is the better fit depends on your goals.
| BBWI | XLV | |
|---|---|---|
Market Cap | $3.81B | — |
Sector | Consumer Cyclical | — |
52-Week High | $31.87 | $168.44 |
52-Week Low | $14.85 | $131.16 |
Enterprise Value | $7.70B | — |
Dividend Yield | 4.24% | — |
Signals from Pluang's Aura AI — not financial advice
BBWI trades at $18.28, down 5.38% over 24 hours, with a bearish technical signal from moving averages. The stock shows attractive valuation metrics with a P/E of 5.36 and P/S of 0.54, while maintaining strong gross margins above 43%. Recent earnings have mostly beaten expectations, and the company is expanding internationally through partnerships with Ulta Beauty and entry into Brazil. Cash flow trends show improvement, with positive net cash flow projected for 2026.
The investment case hinges on BBWI's deep value proposition against declining revenue trends. Key opportunities include international growth and strategic partnerships, while risks involve high debt levels and ongoing revenue pressure. Analyst consensus is mixed with a $22.11 price target suggesting upside potential from current levels.
XLV, the Health Care Select Sector SPDR ETF, trades at $168.44 with a neutral daily change. Technical indicators show a bullish trend from moving averages but oscillators are neutral, with the 6-day RSI at 86.78 suggesting overbought conditions. The fund's low 0.08% expense ratio and defensive healthcare sector exposure attract steady inflows amid market volatility, as highlighted by recent ETF flow reports.
The outlook for XLV is cautiously optimistic, supported by defensive demand and strong sector earnings. Key opportunities include diversification benefits and cost efficiency, while risks involve sector-specific regulatory pressures and broader economic sensitivity. Investors should weigh the ETF's stability against potential growth limitations in a concentrated portfolio.
Trailing returns across standard periods
Latest headlines on both assets
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →